Skip to content
ECAT Documents
“How to interpret the Z-score in survey reports” webinar 2023
A paradigm shift in measuring blood coagulation
A scoring system based on the biological variation
Accuracy
Activated Partial Thromboplastin Time Test (APTT)
Activated Protein C (APC)
Activated Protein C Resistance-APCR
ADAMTS13 and the pathogenesis of Thrombotic Thrombocytopenic Purpura (TTP)
Age-dependent cut-off values for D-Dimer testing
Aggregometry
Algoritm for Laboratory Investigations in Case of a prolonged APTT
An update on new anticoagulation drugs
Analytical Performance Specifications: the benefit for the laboratory!
Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme
Anti-PF4 testing for vaccine- induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide
Anticoagulant
Antifibrinolytic
Antiphospholipid Antibody Assay results and clinical implications
Antiphospholipid antibody solid phase-based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome: reply.
Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome
Antithrombin
Application of thrombo-elastography in clinical practice and how to control quality
Assessment of accuracy of laboratory testing results, relative to peer group consensus values in external quality control, by bivariate z-score analysis: the example of D-Dimer.
Attempts to align research in thrombosis and hemostasis with the In Vitro Diagnostic Medical Device Regulation (IVDR, EuropeanUnion) requirements
Auditing the pre-analytical phase: lessons from 40+ audits across Europe
Autovalidation of coagulation test results
Bethesda Inhibitor Assay (Titer)
Bias
Biochemical background of Lupus Anticoagulant
Biological variation and analytical quality specifications
Biological variation and quality control
Biological Variation in haemostasis
Biological variation of inflammatory and hemostatic markers
Biological variation, quality specifications and Six Sigma
Bleeding Time
Bleeding webinar 2021, von Willebrand
Case studies in Bleeding disorders
Case studies in Thrombophilia
Clot (Blood Clot)
Clotting and Fibrinolysis: an integrated test system
Coagulation (Clotting)
Coagulation Cascade
Coagulation Factors
Common Pathway of Coagulation
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group
Complementarity between Bayesian Internal Quality Control results management and External Quality Assessment bivariate z-score analysis: application to a concrete case study
Contact Activation
Control Plasma
Coumarin
COVID-19 and Haemostasis webinar 2021
COVID-19 and the role of the haemostasis laboratory
Crossroads between cancer and coagulation
Current practice in the pre-analitycal phase
D-dimer – An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World
D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap
D-Dimer: quality of laboratory testing and its implications in clinical practice
Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
Desired tests for monitoring new anticoagulation drugs
Desmopressin Acetate (DDAVP)
Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands
Determination of lot-to-lot variability of reagents
Determination of sigma score based on biological variation for haemostasis assays: fit-for-purpose for daily practice?
Developmental haemostasis: consequences for clinical practice
Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories
Diagnostic Sensitivity
Diagnostic Specificity
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade
Diagnostics in venous thromboembolism: from origin to future prospects
Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: A large international cross-laboratory study
Disseminated Intravascular Coagulation (DIC)
Dysfibrinogenemia
ECAT survey results for HIT
ECAT survey results for low levels of Factor VIII
ECAT survey results on ADAMTS13 testing
ECAT survey results on direct oral anticoagulant testing
ECAT: Towards sustainable EQA
EFLM/EQALM on the laboratory diagnosis of a prolonged APTT
EQA results for POCT INR testing
Establishing reference values – with low number of control samples
External quality assessment of the manual tilt tube technique for prothrombin time testing: a report from the IFCC-SSC/ISTH Working Group on the Standardization of PT/INR
External quality control for CoaguChek XS INR monitors
External quality control: a new decade
Extrinsic Pathway of Coagulation
Factor IX (FIX)
Factor IX Concentrates
Factor V (FV)
Factor V Leiden
Factor VII (FVII)
Factor VIII (FVIII)
Factor VIII inhibitor testing – a way to comparable test results
Factor VIII Inhibitor Testing, the way to better comparison of test results
Factor VIII testing: results of ECAT surveys
Factor X (FX)
Factor XI (FXI)
Factor XII (FXII)
Factor XIII (FXIII)
Fibrin
Fibrinogen (FI) and Fibrinogen Assay
Fibrinolysis
First experience of ECAT with Measurement of New Oral Anticoagulation Drugs
Follow-up of LA positieve patients
Future perspective in quality assurance
Gene therapy, the future in hemophilia treatment?
Generation assays in coagulation and fibrinolysis: Principles and possibilities
Global haemostasis assays: what will be the future?
Guidance for FVIII/FIX Inhibitor testing
Guidance for laboratory testing of DOACS
Haemophilia treatment and laboratory testing
Haemophilia, new development in patient treatment
Have international standards in haemostasis improved comparability of laboratory results?
Hemophilia A
Hemophilia and gene therapy
Hemophilia B
Hemostasis
Heparin Induced Thrombocytopenia; a diagnostic challenge
Heparin-Unfractionated
Heparin‐induced thrombocytopenia: An international assessment of the quality of laboratory testing
High Molecular Weight Kininogen (HK)
Hirudin
HIT and VITT: is there a bridge?
How do laboratories interpret unexpected APTT prolongation?
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey
How to assure the quality of POCT testing
How to evaluate your Z-score?
How to interpret the Z-score in survey reports (theory and practical examples)
How to measure low levels of Factor VIII and IX
How to use EQA results in the laboratory?
How to use EQA results within the laboratory
Hypofibrinogenemia
Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories
Imprecision
Inherited FXIII deficiency: laboratory diagnosis
Inhibitor
Inhibitor testing: positive or negative? True or False?
INR-International Normalized Ratio (PT-INR)
Interference of DOACS in coagulation tests
Interferences in Lupus testing
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors
International external quality assessment for measurements of direct oral anticoagulants: results and recommendations.
International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents
International Normalized Ratio for monitoring therapy with vitamin K Antagonists
Interpretation and management of INR results: a case history based survey in 13 countries
Intrinsic Pathway of Coagulation
Introduction on Inhibitor Testing
Introduction on Inhibitor Testing
Is standardisation in coagulation feasible?
Is therapeutic quality influenced by choice of thromboplastin?
Is there a need to measure ROTEM/TEG
ISI-International Sensitivity Index
Laboratory accreditation: the value of quality improvement
Laboratory assays for the measurement of Factor VIII and IX
Laboratory assesment of direct and indirect thrombin inhibitors
Laboratory diagnosis of platelet disorders
Laboratory Guidelines for Antithrombin, Proteins C and S, and APC-Resistance Testing
Laboratory issues related to the measurement of efanesoctocog alfa webinar 2025
Laboratory measurement of extended half-life FIX
Laboratory measurement of extended half-life FVIII
Laboratory testing for heparin induced thrombocytopenia
Lack of grading agreement among international hemostasis external quality assessment programs
Low Molecular Weight Heparin (LMWH)
Low von Willebrand Factor and diagnostic treshold
Lupus Anticoagulant (LA)
Lupus Anticoagulant: Do guidelines work in practice?
Lupus Anticoagulant: Remarkable observations in ECAT surveys
Lupus Anticoagulant: Update of the SSC guidelines
Lupus Anticoagulants webinar 2023
Measurement of new oral anticoagulans
Medical device thrombosis
Method validation for haemostasis assays
Monitoring new oral anticoagulants-Practical approach
New developments in haemophilia treatment
New developments in laboratory tests
New developments within ECAT
Next-generation antithrombin diagnostics by mass spectrometry
One-stage clotting assay versus chromogenic testing in the diagnosis of haemophilia patients
Performance of factor IX extended half-life product measurements in external quality control assessment programs
Phospholipids
Plasminogen
Platelet
Platelet Function Testing
Platelet function testing: laboratory tests and quality control
Point of care testing for haemostasis. The clinician’s point of view
Point of care testing for haemostasis. The laboratories point of view
Potency labelling of extended half-life FVIII en FIX products
Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
Pre-analytical Variables in the Hemostasis Laboratory
Prekallikrein
Procedures and barriers for the introduction of a new or improved method: the example of inhibitor testing
Prothrombin (FII)
PT-Prothrombin Time and Prothrombin Time Ratio
Quality Assurance of extended half-life products
Quality assurance of the entire diagnostic process
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data
Quality planning in the Haemostasis Laboratory
Reference Interval (range)
Reference Intervals: Practical Approaches
Resistance to change: How to facilitate the implementation of new methods in the lab
Results of ECAT EQA programme on DOACS
Results of ECAT EQA programme on ROTEM/TEG
Results of the interpretative platelet surveys
Results of the workshop on platelet function testing
Rotem, does it have value at the cardiothoracic operation theatre?
Serine Proteases
Short-term biological variation of coagulation and fibrinolytic measurands
Sinus thrombosis, past, present and future
Slope and parallelism of APTT dilution curves: new insights
Subcommittee on Plasma Coagulation Inhibitors. Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH.
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
Test and equipment evaluation, a practical approach
TFPI: new insights in an old inhibitor
The antiphospholipid syndrome: a laboratory phenomenon?
The CLSI & BCSH algorithms for Lupus anticoagulant testing
The diagnosis of von Willebrand Disease
The differential diagnosis between TTP and atypical HUS
The effect of local ISI calibration on the inter-laboratory variation of the INR
The fibrinolytical system, what and how to measure?
The future of anticoagulation
The future of the laboratory diagnosis of thrombofilia
The importance of thromboelastography in clinical practice
The intensive care unit during the COVID-19 pandemic
The laboratory diagnosis and classification of FXIII deficiencies
The laboratory diagnosis of vWD: current insights
The new CLSI guideline on Lupus Anticoagulant testing
The pathophysiology of HIT
The pathophysiology of Lupus Anticoagulant and the consequences for the laboratory diagnostics
The performance of FVIII and FIX measurement in ECAT surveys
The relevance of pre-operative hemostasis screening
The result of the ECAT HIT surveys
The results of fibrinolytic surveys
The results of the ECAT pilot study on FXIII testing
The results of the workshop on inhibitor testing
The results of thromboelastography: does it fit with laboratory testing?
The role of contact activation in thrombosis and beyond
The role of molecular biology in the diagnosis of impaired haemostasis
The SSC algorithm for Lupus testing
The use of Guidelines in Haemostasis Laboratory Testing
The use of snake venoms in the coagulation laboratory
Thrombin
Thrombin Time (TT) Test
Thrombogenomics
Thrombomodulin
Thromboplastin
Thrombosis webinar 2021, Antiphospholipid Antibody, Anticoagulation bridging
Thrombotic APS pathophysiology: consequences for laboratory diagnosis
Thrombus (plural form is Thrombi)
Tissue Factor (TF)
Towards diagnostic quality control: a pilot study on acquired inhibitors
Towards harmonization of external qualityassessment/proficiency testing in hemostasis
Treatmentof patients with extended half-life FVIII and FIX products
Update on diagnostic testing for platelet function disorders: What is practical and useful?
Vitamin K
Von Willebrand Factor (VWF)
What are the implications of the new IVD regulation for the daily laboratory practice?
What information does the doctor expect from the laboratory? What kind of services can a laboratory deliver to the physician?
When Haemostasis Assays Mislead
Questions or suggestions?
Clotpedia Support Form
Submit
Success
